The European Medicines Agency (EMA) has published a document detailing its methodology for monitoring potential vulnerabilities in the medicine supply chains. The agency said its new framework is intended to prevent potential shortages of drugs considered especially important on the Union List of Critical Medicines (ULCM).
On 10 March, EMA published the document that was originally adopted by its Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) on 17 November 2025. The agency said the methodology is intended to be practical and implementable, while avoiding duplication of existing processes and taking on unnecessary burdens...[EMA]
